Angelique Wong1, Supakarn Tayjasanant2, Alfredo Rodriguez-Nunez3, Minjeong Park4, Diane Liu4, Kresnier Perez Zapata1, Julio Allo1, Susan Frisbee-Hume1, Janet Williams1, Eduardo Bruera1. 1. Departments of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2. Siriraj Palliative Care Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. 3. Palliative Care and Continuing Care Program, Faculty of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. 4. Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abstract
INTRODUCTION: To compare the time duration of self-completion (SC) of the Edmonton Symptom Assessment Scale (ESAS) by patients with advanced cancer (ACPs) versus assisted completion (AC) with a health care professional. MATERIALS AND METHODS: In this randomized comparison of ACPs seen in initial consultation at the outpatient Supportive Care Center at MD Anderson, ACPs who have never completed the ESAS at MD Anderson were allocated (1:1) to either SC of the ESAS form versus AC by a nurse. Time of completion was measured by the nurse using a stopwatch. Patients completed the Rapid Estimate of Adult Literacy in Medicine (REALM) test prior to administration of the ESAS. In the SC group, the nurse reviewed the responses to verify that the reported ESAS scores were correct. RESULTS: A total of 126 ACPs were enrolled (69 patients to AC and 57 to SC). Seventy-one patients were female, median age was 60 years, and median REALM score was 65. Median (interquartile range) time (in seconds) of SC was significantly less than AC (73 [42.9-89.1] vs. 109 [79.5-136.7], p < .0001). With nurse review time included, median time of SC increased to 117 seconds, which was not significantly different from AC (p = .28). Lower literacy (REALM) score and shortness of breath were significantly associated with increased completion time (p = .007). CONCLUSION: Regular use of ESAS will have minimal impact on clinical time, as it can be completed in about 1 minute and provides a concise yet comprehensive and multidimensional perspective of symptoms that affect quality of life of patients with cancer. IMPLICATIONS FOR PRACTICE: Because the Edmonton Symptom Assessment Scale can be completed in less than 2 minutes, hopefully the routine use of this simple yet comprehensive and multidimensional symptom assessment tool will be used at all medical visits in all patients with cancer so that the timely management of symptoms affecting patients' lives and treatment courses can occur, further enhancing personalized cancer care.
INTRODUCTION: To compare the time duration of self-completion (SC) of the Edmonton Symptom Assessment Scale (ESAS) by patients with advanced cancer (ACPs) versus assisted completion (AC) with a health care professional. MATERIALS AND METHODS: In this randomized comparison of ACPs seen in initial consultation at the outpatient Supportive Care Center at MD Anderson, ACPs who have never completed the ESAS at MD Anderson were allocated (1:1) to either SC of the ESAS form versus AC by a nurse. Time of completion was measured by the nurse using a stopwatch. Patients completed the Rapid Estimate of Adult Literacy in Medicine (REALM) test prior to administration of the ESAS. In the SC group, the nurse reviewed the responses to verify that the reported ESAS scores were correct. RESULTS: A total of 126 ACPs were enrolled (69 patients to AC and 57 to SC). Seventy-one patients were female, median age was 60 years, and median REALM score was 65. Median (interquartile range) time (in seconds) of SC was significantly less than AC (73 [42.9-89.1] vs. 109 [79.5-136.7], p < .0001). With nurse review time included, median time of SC increased to 117 seconds, which was not significantly different from AC (p = .28). Lower literacy (REALM) score and shortness of breath were significantly associated with increased completion time (p = .007). CONCLUSION: Regular use of ESAS will have minimal impact on clinical time, as it can be completed in about 1 minute and provides a concise yet comprehensive and multidimensional perspective of symptoms that affect quality of life of patients with cancer. IMPLICATIONS FOR PRACTICE: Because the Edmonton Symptom Assessment Scale can be completed in less than 2 minutes, hopefully the routine use of this simple yet comprehensive and multidimensional symptom assessment tool will be used at all medical visits in all patients with cancer so that the timely management of symptoms affecting patients' lives and treatment courses can occur, further enhancing personalized cancer care.
Authors: Dena Schulman-Green; Emily J Cherlin; Ruth McCorkle; Melissa D A Carlson; Karen Beckman Pace; Janet Neigh; Meliessa Hennessy; R Johnson-Hurzeler; Elizabeth H Bradley Journal: J Palliat Med Date: 2010-02 Impact factor: 2.947
Authors: Nancy S Morris; Terry S Field; Joann L Wagner; Sarah L Cutrona; Douglas W Roblin; Bridget Gaglio; Andrew E Williams; Paul J K Han; Mary E Costanza; Kathleen M Mazor Journal: J Health Commun Date: 2013
Authors: Julie Hallet; Jesse Zuckerman; Matthew P Guttman; Tyler R Chesney; Barbara Haas; Alyson Mahar; Antoine Eskander; Wing C Chan; Amy Hsu; Victoria Barabash; Natalie Coburn Journal: Ann Surg Oncol Date: 2022-09-06 Impact factor: 4.339
Authors: Ishwaria M Subbiah; Maira M Charone; Jason Roszik; Ali Haider; Marieberta Vidal; Angelique Wong; Eduardo Bruera Journal: JAMA Netw Open Date: 2021-07-01